Liora ter Horst

Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial

Alexander P. J. Vlaar, Sanne de Bruin, Matthias H. Busch et al. · The Lancet Rheumatology · 2020 · 200 citations · Full text

Life Sciences, Immunology, Infectious Diseases +8

Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Alexander P. J. Vlaar, Martin Witzenrath, Pieter van Paassen et al. · The Lancet Respiratory Medicine · 2022 · 142 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +12

Pneumococcal Meningitis in Adults: A Prospective Nationwide Cohort Study Over a 20-year Period

Diederik L H Koelman, Matthijs C. Brouwer, Liora ter Horst et al. · Clinical Infectious Diseases · 2021 · 69 citations · Full text

Medicine, Infectious Diseases, Pediatrics +15

Community-acquired Bacterial Meningitis in Adults With Cerebrospinal Fluid Leakage

Liora ter Horst, Matthijs C. Brouwer, Arie van der Ende et al. · Clinical Infectious Diseases · 2019 · 61 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +10

Diagnostic accuracy of inflammatory markers in adults with suspected central nervous system infections

Sabine E. Olie, Steven L. Staal, Liora ter Horst et al. · Journal of Infection · 2024 · 28 citations · Full text

Veterinary Medicine, Infectious Diseases, Neurology +17